Ceren Guzelalp
Director, Early Access & Patient Support, Europe ACADIA Pharmaceuticals Inc.
Ceren Güzelalp is Director of Early Access and Patient Support Europe at Acadia Pharmaceuticals, where she leads the development of patient-centred access strategies across complex European markets. With over a decade of experience spanning market access, public affairs, regulatory, and patient services, she specialises in connecting policy, patient advocacy, and commercial strategy to enable earlier and more sustainable access to treatment. Ceren brings particular expertise in rare diseases, working closely with patient organisations, policymakers, and healthcare systems to shape access pathways that reflect real-world patient needs.
Seminars
Tuesday 20th October 2026
Delivering Successful Early Access Across Europe: A Real-World Case Study on Programme Strategy & Execution
11:00 am
- Exploring ACADIA’s European early access journey: how different country pathways and programme types shaped execution, timelines, and operational complexity
- Sharing first-hand experience of managing multi-country programmes: where structured, centrally coordinated approaches increased cross-functional burden, resource demand, and delivery risk
- Demonstrating how pragmatic, country-level and ad-hoc access routes enabled faster patient access
- Lessons learned on aligning programme design with organisational readiness, resourcing, and anticipated regulatory uncertainty to ensure sustainable, successful delivery
